{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T23:36:24Z","timestamp":1768520184602,"version":"3.49.0"},"posted":{"date-parts":[[2024,12,23]]},"group-title":"Neuroscience","reference-count":25,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,12,23]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  Methylglyoxal (MG) is an endogenously produced non-enzymatic side product of glycolysis that acts as a partial agonist at GABA\n                  <jats:sub>A<\/jats:sub>\n                  receptors. MG that is metabolized by the enzyme glyoxalase-1 (GLO1). Inhibition of GLO1 increases methylglyoxal levels, and has been shown to modulate various behaviors, including decreasing seeking of cocaine-paired cues and ethanol consumption. The goal of these studies was to determine if GLO1 inhibition could alter cocaine-or oxycodone-induced locomotor activation and\/or conditioned place preference (CPP) to cocaine or oxycodone. We used both pharmacological and genetic manipulations of GLO1 to address this question. Administration of the GLO1 inhibitor s-bromobenzylglutathione cyclopentyl diester (pBBG) did not alter the locomotor response to cocaine or oxycodone. Additionally, pBBG had no significant effect on place preference for cocaine or oxycodone. Genetic knockdown of\n                  <jats:italic>Glo1<\/jats:italic>\n                  , which is conceptually similar to pharmacological inhibition, did not have any significant effects on cocaine place preference, nor did\n                  <jats:italic>Glo1<\/jats:italic>\n                  overexpression affect locomotor response to cocaine. In summary, our results show that neither pharmacological nor genetic manipulations of GLO1 influence locomotor response or CPP to cocaine or oxycodone.\n                <\/jats:p>","DOI":"10.1101\/2024.12.23.630123","type":"posted-content","created":{"date-parts":[[2024,12,26]],"date-time":"2024-12-26T11:00:13Z","timestamp":1735210813000},"source":"Crossref","is-referenced-by-count":0,"title":["Investigating the Role of Glyoxalase 1 as a Therapeutic Target for Cocaine and Oxycodone Use Disorder"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-8295-6375","authenticated-orcid":false,"given":"Elizabeth","family":"Alcantara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4303-2478","authenticated-orcid":false,"given":"Michelle R.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara A.","family":"Ortez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Ilustrisimo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bloom","family":"Stromberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3722-7578","authenticated-orcid":false,"given":"Amanda M.","family":"Barkley-Levenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3634-0747","authenticated-orcid":false,"given":"Abraham A.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024122622533407000_2024.12.23.630123v1.1","doi-asserted-by":"publisher","DOI":"10.1111\/acer.13623"},{"key":"2024122622533407000_2024.12.23.630123v1.2","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11010127"},{"key":"2024122622533407000_2024.12.23.630123v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2018.03.001"},{"key":"2024122622533407000_2024.12.23.630123v1.4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI61319"},{"key":"2024122622533407000_2024.12.23.630123v1.5","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20081188"},{"key":"2024122622533407000_2024.12.23.630123v1.6","unstructured":"Harp SJ (2021) Differences in Fentanyl-Induced Conditioned Place Preference and Open Field Activity in A\/J and B6J Mice; Potential Role for Glyoxalase 1. North Carolina State University"},{"key":"2024122622533407000_2024.12.23.630123v1.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2021.113630"},{"key":"2024122622533407000_2024.12.23.630123v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2023.105209"},{"key":"2024122622533407000_2024.12.23.630123v1.9","doi-asserted-by":"publisher","DOI":"10.1038\/nature04250"},{"key":"2024122622533407000_2024.12.23.630123v1.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2013.04.028"},{"key":"2024122622533407000_2024.12.23.630123v1.11","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-020-01013-y"},{"key":"2024122622533407000_2024.12.23.630123v1.12","doi-asserted-by":"publisher","DOI":"10.1038\/mp.2017.14"},{"key":"2024122622533407000_2024.12.23.630123v1.13","doi-asserted-by":"publisher","DOI":"10.1111\/adb.12333"},{"key":"2024122622533407000_2024.12.23.630123v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2008.02.010"},{"key":"2024122622533407000_2024.12.23.630123v1.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2013.06.010"},{"key":"2024122622533407000_2024.12.23.630123v1.16","doi-asserted-by":"publisher","DOI":"10.1007\/s00213-005-2259-6"},{"key":"2024122622533407000_2024.12.23.630123v1.17","doi-asserted-by":"publisher","DOI":"10.1151\/spp053113"},{"key":"2024122622533407000_2024.12.23.630123v1.18","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a012195"},{"key":"2024122622533407000_2024.12.23.630123v1.19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb06680.x"},{"key":"2024122622533407000_2024.12.23.630123v1.20","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.108.150011"},{"key":"2024122622533407000_2024.12.23.630123v1.21","unstructured":"Substance Abuse and Mental Health Services Administration (2024) Key substance use and mental health indicators in the United States: Results from the 2023 National Survey on Drug Use and Health. (HHS Publication No. PEP24-07-021, NSDUH Series H-59). Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration."},{"key":"2024122622533407000_2024.12.23.630123v1.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2012.02.016"},{"key":"2024122622533407000_2024.12.23.630123v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/37610"},{"key":"2024122622533407000_2024.12.23.630123v1.24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004649"},{"key":"2024122622533407000_2024.12.23.630123v1.25","doi-asserted-by":"publisher","DOI":"10.1038\/s41593-023-01452-y"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.12.23.630123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T07:44:34Z","timestamp":1768463074000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2024.12.23.630123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":25,"URL":"https:\/\/doi.org\/10.1101\/2024.12.23.630123","relation":{},"subject":[],"published":{"date-parts":[[2024,12,23]]},"subtype":"preprint"}}